Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and pharmacokinetics of eflapegrastim in pediatric patients with solid tumors or lymphoma undergoing myelosuppres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumor

Drugs mentioned

• eflapegrastim (eflapegrastim)

Snippet

Sponsor: Spectrum Pharmaceuticals, Inc | Conditions: Solid Tumors, Lymphoma | Phase 2 | Status: RECRUITING